Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma (Q37354301)
scientific article published on 10 June 2009
Language:
(P31) (Q13442814)
(P50) (Q60687367)
(P304) 282-291
(P407) (Q1860)
(P433) 3
(P478) 146
(P577) Wednesday, June 10, 2009
(P921) (Q408004)
(Q412323)
(P1433) (Q4970200)
(P1476) "Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma" (language: en)
(P2093) Jonathan W Friedberg
Jennifer L Kelly
Donna Neuberg
Derick R Peterson
Jeffery L Kutok
Rabih Salloum
Thomas Brenn
David C Fisher
Elizabeth Ronan
Virginia Dalton
Lynn Rich
Diana Marquis
Paul Sims
Paul G Rothberg
Richard I Fisher
Robert Coffman
Tim Mosmann
Arnold S Freedman
(P2860) (Q33380807)
(Q36743909)
(Q37125104)
(Q36961075)
(Q37050998)
(Q36718925)
(Q33372646)
(Q36568856)
(Q27861084)
(Q34561857)
(Q33773306)
(Q37371654)
(Q28251216)
(Q29547848)
(Q40062910)
(Q40197961)
(Q40215064)
(Q40536409)
(Q40562102)
(Q40617741)
(Q41690264)
(Q53418146)
(Q51979013)
(Q53253117)
(Q50764033)
(Q46525283)
(Q54702413)
(Q45029588)
(Q51026982)
(Q57279527)
(Q79394017)
(Q80736139)
(Q81463912)
(Q81918934)
(Q74238074)
(Q77387054)
(Q58415142)
(Q81290158)
(Q81474815)
(Q61810995)
(Q81520263)
other details
description scientific article published on 10 June 2009

External Links